Sigma Pharmaceuticals SWOT Analysis
Here is a detailed SWOT analysis of Sigma Pharmaceuticals covering strengths, weaknesses, opportunities and threats.
Sigma Pharmaceuticals Strengths
- Most trusted brand of Australia
- Strong wholesale and distribution network
- One of the fastest growing players by sales domestic consumer healthcare market, which deals with non-prescription products in the healthcare and wellness segment
- Advanced technological support like pick-to-light (PTL) system and adapted voice-directed picking as part of their comprehensive logistics systems
- It is the owner of the big retail brands Amcal Max, Amcal and Guardian
Above are the strengths in the SWOT Analysis of Sigma Pharmaceuticals. The strengths of Sigma Pharmaceuticals looks at the key internal factors of its business which gives it competitive advantage in the market and strengthens its position.
Sigma Pharmaceuticals Weaknesses
- Dependent on limited number of customers
- The company may lose focus if they enter into different segments (personal care, well-being products) all together
- The market is dominated (90% of market) by 3 major players – API, Sigma, and Symbion Health; gaining more market share is a difficult task
These were the weaknesses in the Sigma Pharmaceuticals SWOT Analysis. The weaknesses of a brand are certain aspects of its business which it can improve.
Sigma Pharmaceuticals Opportunities
- Awareness about healthcare is rapidly increasing, Sigma has a huge space to come up with healthcare and well-being products
- It can divest pharmaceutical assets which could help the company in increasing its focus on core business
- There is scope for development in areas of well-being and personal care. For example, Sigma’s key launch in 2013, Colour THEORY : selling high quality cosmetics which are only available at Amcal Max, Amcal and Guardian pharmacies
Above we covered the opportunities in Sigma Pharmaceuticals SWOT Analysis. The opportunities for any brand can include prospects of future growth.
Sigma Pharmaceuticals Threats
- Reforms in pharmaceutical pricing scheme namely PBS reforms can create trouble for the company
- The margins of the company may be hurt because of PBS because it may create a trade barrier between Australian and U.S. drug companies
- Stringent rules against clinical trials and quality of drugs will require more stringent measures from the company leading to increased costs
The threats in the SWOT Analysis of Sigma Pharmaceuticals are as mentioned above. The threats for any business can be external factors which can negatively impact its business.
Hence this concludes the Sigma Pharmaceuticals SWOT analysis.
About Sigma Pharmaceuticals
The table below gives the brand overview along with its target market, segmentation, positioning & USP
| Sigma Pharmaceuticals Overview | |
|---|---|
| Parent Company |
Sigma is parent company to pharmacy retail brands: Amcal Max, Amcal and Guardian |
| Category |
Pharmaceuticals |
| Sector | |
| Tagline/ Slogan |
AMCAL- Expert advice for every Australian; Guardian Pharmacy – Advice. Trust. Care. |
| USP |
Australia’s partner of choice for health, beauty and wellbeing |
| Sigma Pharmaceuticals STP | |
| Segmentation |
People who looking for quality drugs at an affordable price, seekers of healthcare products |
| Target Market |
Healthcare professionals, wholesalers, generic distributors, and hospitals |
| Positioning |
Quality and affordable pharmaceutical products |
Browse marketing analysis of more brands and companies similar to Sigma Pharmaceuticals. This section covers SWOT Analysis along with Segmentation, Target Market, Positioning & USP of more than 2000 brands from over 20 industry sectors.
Continue Reading:
The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the brand or add a new one to SWOT Analysis section : Contribute
